Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=934312

Efficacy and tolerability of fluvastatin extended-release delivery system : A pooled analysis

Author
BALLANTYNE, Christie M1 ; PAZZUCCONI, Franco2 ; PINTO, Xavier3 ; RECKLESS, John P4 ; STEIN, Evan5 ; MCKENNEY, James6 ; BORTOLINI, Michele7 ; YANN TONG CHIANG8
[1] Baylor College of Medicine, Houston, Texas, United States
[2] Ospedale Niguarda Ca'Granda, Centro E Grossi-Paoletti, Padiglione Vergani, Piazza Ospedale Maggiore, Milan, Italy
[3] Ciutat Sanitaria i Universitaria de Bellvitge, Unidad de Arteriosclerosis, Servicio de Medicina Interna, Hospitalet de Llobregat, Barcelona, Spain
[4] Royal United Hospital, Bath, United Kingdom
[5] Medical Research Laboratories, Highland Heights, Kentucky, United States
[6] National Clinical Research Inc, Richmond, Virginia, United States
[7] Novartis Pharma AG, Basel, Switzerland
[8] Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States
Source

Clinical therapeutics. 2001, Vol 23, Num 2, pp 177-192 ; ref : 30 ref

ISSN
0149-2918
Scientific domain
Pharmacology drugs
Publisher
Excerpta Medica, Belle Mead, NJ
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Chimiothérapie Cholestérol HDL Cholestérol LDL Cholestérolémie Etude comparative Fluvastatine Forme libération contrôlée Forme libération immédiate Forme pharmaceutique Homme Hydroxymethylglutaryl-CoA reductase Hypercholestérolémie Hypolipémiant Inhibiteur enzyme Lipide Traitement Triglycéridémie Statine dérivé Dyslipémie Enzyme Hyperlipoprotéinémie Métabolisme pathologie Oxidoreductases
Keyword (en)
Chemotherapy Cholesterol HDL Cholesterol LDL Cholesterolemia Comparative study Fluvastatin Controlled release form Immediate release form Dosage form Human Hydroxymethylglutaryl-CoA reductase Hypercholesterolemia Antilipemic agent Enzyme inhibitor Lipids Treatment Triglyceridemia Statin derivative Dyslipemia Enzyme Hyperlipoproteinemia Metabolic diseases Oxidoreductases
Keyword (es)
Quimioterapia Colesterol HDL Colesterol LDL Colesteremia Estudio comparativo Fluvastatina Forma liberación controlada Forma liberación inmediata Forma farmacéutica Hombre Hydroxymethylglutaryl-CoA reductase Hipercolesterolemia Hipolipemiante Inhibidor enzima Lípido Tratamiento Trigliceridemia Dislipemia Enzima Hiperlipoproteinemia Metabolismo patología Oxidoreductases
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02N General and cellular metabolism. Vitamins

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
934312

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web